← Evidence map

ReviewCancers2022

Progress on Denosumab Use in Giant Cell Tumor of Bone: Dose and Duration of Therapy.

Feifan Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36497239